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Summary We report ﬁve cases of coastal chondrosarcoma (CS) in four women and one man
between 28 and 49 years of age. In four cases, the tumor had spread and inﬁltrated the adjacent
structures (soft tissues, thoracic vertebrae, mediastinum, etc.). CS was diagnosed based either
on wide surgical resection specimens in three patients, or on tumor biopsies in two cases. The
CS was grade I in one patient, grade II in three cases, and grade III in one case. Wide surgi-
cal resection which was performed in three patients was associated in one case with adjuvant
radiotherapy and chemotherapy. In the three cases, the disease natural history appeared favor-
able after a follow-up duration ranging from 1month to 4 years. Two patients died, one after
radiotherapy and chemotherapy done immediately after diagnosis as a result of the large size
and invasive nature of the tumor. Coastal CS is characterized by a distinct potential for locore-
gional and distant metastasis. Diagnosis remains anatomopathological. Wide surgical resection
is the only demonstrated curative treatment, even for high-grade CS.
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alignant primary bone tumors of the thoracic wall are
are. They account for 4.5 to 8% of all bone tumors. Most
ften, they are located in the ribs and are predominantly
hondrosarcoma (CS), which alone accounts for 40% of all
alignant rib tumors [1]. Its diagnosis is suspected based on
maging studies, with deﬁnitive diagnosis based on histology.
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S is a malignant tumor with cartilaginous differentiation,
ith no bone or osteoid production, but it can contain foci of
umor-induced or enchondral ossiﬁcation. It is characterized
y a high potential for locoregional invasion and recurrence
fter treatment [2]. Five cases of costal CS are reported
Table 1).
bservationsbservation No. 1
41-year-old female patient was hospitalized for a left-
ided cervicothoracic mass that had been evolving for
served.
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Table 1 Clinical and radiological features of ﬁve cases of costal chondrosarcoma.
Case Sex/Age Circumstances at
discovery
Imaging Size/grade Treatment Follow-up/progression
1 F/41 years Left cervicothoracic
mass + cervicobrachial
neuralgia
Parietal tissue mass,
anterior-external, centered
on 1st rib. Central necrosis
and peripheral contrast
agent uptake. Parietal,
mediastinal inﬁltration and
invasion of large venous
trunks
15 cm/GII Radiotherapy +
chemotherapy
Coastal and vertebral
extension + lung
metastases. Death
2 F/42 years Chest pain Apical opacity ﬂaring
anterior 1st rib with cortical
rupture
4 cm/GI Resection of
superior arc of
1st rib
3 years/good
3 M/28 years Swelling under axilla
ﬁstulized at skin
Expansive tissue process
inﬁltrating soft tissue and
wall +multiple rib fractures
20 cm/GIII Peritectomy 1month/lost to
follow-up
4 F/49 years Right cervicobrachial
neuralgia
Posterior and superior
mediastinal mass inﬁltrating
thoracic vertebra and
surrounding vessels
6 cm/GII En bloc resection
planned but not
performed
4months/death
5 F/31 years Chest pain Mediastinal mass 5 cm
posterior, with lumpy
calciﬁcations in
periphery + fracture of
6th rib
8 cm/GII Surgery +
chemotherapy and
radiotherapy
4 years/good
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Figure 1 Axial thoracic CT: large tumor involving the left ﬁrst
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aib with homolateral mediastinal and soft tissue extension, with
high peripheral contrast-enhancement and a central necrosis
case 1).
months, with persistent symptoms of cervicobrachial neu-
algia. The physical examination found a 15-cm mass at its
idest point ﬁlling the left clavicular fossa. The chest X-ray
howed an opacity at the apex of the left lung, measur-
ng 8 cm at its longest axis, extending to the mediastinum
nd the lateral thoracic wall. The thoracic computerized
omography (CT) scan demonstrated a parietal tissue mass,
nteroexternal, substantially enhanced in its periphery after
njection of contrast agent and delimiting central necrotic
ones. This mass was centered on the cartilage of the ﬁrst
eft rib with its mid and posterior arc fractured. This mass
resented wide ipsilateral parietal and mediastinal exten-
ion with invasion and thrombosis of the left innominate
enous trunk and the left jugular vein (Fig. 1). Abdominal
ltrasound and CT showed no secondary lesions. The histo-
ogical exam of the ultrasound-guided mass biopsy showed
rade II CS. Given the extent of the tumor’s locoregional
nvasion, surgical resection was not planned. Antalgic radio-
herapy at a dose of 20Gy on the chest wall associated with
our courses of palliative chemotherapy with ifosfamide,
romitexan®, dacarbazine, and doxorubicin were adminis-
ered. Clinical progression was marked by a slight reduction
n the tumor’s size in the left supraclavicular fossa, likely
econdary to the resorption of the peritumoral edema. Nev-
rtheless, the follow-up thoracic CT scan showed tumor
xtension with osteolysis of the second rib and the ﬁrst tho-
acic vertebra as well as the appearance of secondary lung
odules. A new course of chemotherapy was decided but the
atient died from the disease after the 12th round.
bservation No. 2
42-year-old woman consulted for chest pain on the right
ide, which had appeared 5 years before, irradiating to the
psilateral upper limb. X-rays of the thorax at this time
howed a right apical opacity, 5-cm at its widest point, oval
ith clear limits (Fig. 2). The radiological diagnosis argued
n favor of a benign lesion. The patient was lost to follow-up
or 5 years. The follow-up chest X-ray revealed a slight 0.5-
a
t
t
t
pigure 2 Chest X-ray: a 5-cm, well-circumscribed and oval
esion of the right upper chest wall (case 2).
m increase in the size of the lesion at its largest diameter.
he thoracic CT showed an expansive lesion of the internal
xtremity of the anterior arc of the ﬁrst right rib, ﬂaring
he cortex, which was broken in several spots. The ante-
ior arc of the ﬁrst rib was resected via the axilla using
Roos approach: an incision between the external edge
f the pectoralis major muscle in front and the external
dge of the latissimus dorsi muscle in back, done carefully
ith the patient in the lateral decubitus position and the
rm maintained at 90◦. Macroscopically, the rib segment
easured 6 cm in length, the seat of an osteolysis shap-
ng a recess partially occupied by a tumor nodule measuring
cm at the widest axis, with a shiny chondroid aspect. On
istological examination, this nodule had the aspect of well-
ifferentiated grade I CS, extending in a ﬁne line along the
ompartment wall. The limits of the resections were not
nﬁltrated. Follow-up thoracic CT and bone scintigraphy,
one 3 years after surgery because of the onset of thoracic
ain on the right side, were normal with no signs indicating
ecurrence or metastasis.
bservation No. 3
28-year-old male, who had been operated on 4 years
efore for a hydatid cyst of the eighth left rib, consulted
or swelling under the left axilla. The 20× 15-cm tumor was
ainless, ﬁrm, and ﬁstulized at the skin by an oriﬁce sup-
urating purulent secretions. The scar of the thoracotomy
as good quality. The thoracic X-ray showed a left-sided
aracardiac opacity, oval in shape, heterogenous, and poorly
imited, 16 cm at the largest diameter, associated with
ostal lysis. The rib cage showed loss of bony segments in
he posterior arcs of the sixth and seventh left ribs and
fracture of the eighth left rib (Fig. 3). The CT showed
n expansive process inﬁltrating the soft tissues of the left
xillary region, with a lateral parietal extension, without
ffecting the parenchyma of the lung, associated with frac-
ure of the sixth, seventh, and eighth ribs. During surgery,
he tumor was found to extend to the spinal cord up to
he anterior angle of the ribs. A peritectomy removing the
osterior and lateral arcs of the sixth, seventh, and eighth
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heterogenous signal on the T2-weighted sequences, with
mostly heterogenous peripheral enhancement after injec-
tion of gadolinium. This aspect suggested a nerve sheath
tumor that had developed at the posterior mediastinum.Figure 3 Plain roentgenogram shows bone destruction involv-
ing the posterior sixth and seventh ribs with osteolysis of the
eighth rib, adjacent to a left pericardial heterogeneous mass
(case 3).
ribs was performed. On macroscopic examination, the surgi-
cal specimen weighed 1350 g and measured 25× 16 cm. The
whitish-grey tumor with a few necrotic-hemorrhagic reorga-
nizations, was inﬁltrating the three ribs. The limits of the
surgical resection were healthy. The histological examina-
tion showed that the tumor corresponded to grade III CS. The
immediate and delayed postoperative course was unevent-
ful. The patient was discharged on the tenth postoperative
day, with a satisfactory follow-up chest X-ray. Seen 1month
after the intervention, the patient was doing well and has
since been lost to follow-up.
Observation No. 4
A 49-year-old female patient consulted for cervicobrachial
neuralgia on the right side occurring over several months.
The clinical examination showed nothing in particular. The
frontal chest X-ray showed a rounded right-sided paratra-
cheal opacity, with well-deﬁned limits, measuring 6 cm at its
widest point. The thoracic CT showed a heterogenous mass
of the upper and mid sections of the posterior mediastinum,
the seat of nodular and arciform calciﬁcations (Fig. 4). Tho-
racic magnetic resonance imaging (MRI) showed that this
mass was centered on the posterior arc of the second right
rib, invading the second thoracic vertebra with no intra-
luminal extension and pushing the trachea and the right
subclavicular artery toward the left. Cervical and abdomi-
nal ultrasound did not bring out secondary locations. Several
biopsies of the tumor were done by cervicotomy. On histo-
logical examination, certain biopsy fragments showed the
aspect of grade II myxoid CS that was focally necrotic. En
bloc resection of the tumor by median sternotomy enlarged
by a cervicotomy was planned but the patient died before
the surgery, 4months after the biopsy, because of substan-
tial invasion of the trachea.
F
tigure 4 Axial thoracic CT: large tumor arising from the pos-
erior mediastinic space with arciform calciﬁcations (case 4).
bservation No. 5
31-year-old female was hospitalized with thoracic pain
n the left side with intercostal irradiation. The physical
xamination found pain on pressure of the left sixth costal-
ertebral joint. At the sixth rib’s posterior arc, the chest
-ray revealed a heterogenous opacity, with clear exter-
al limits and indistinct internal limits. The thoracic CT
howed a posterior mediastinal mass, hypodense, 5 cm at its
idest point, with nodular lumpy calciﬁcations in the periph-
ry. The tumor seemed to thicken the surrounding epidural
paces and did not enhance after injection of contrast agent.
t was associated with a fracture of the posterior arc of the
ixth rib. The thoracic MRI demonstrated an oval posterior
ediastinal mass at the left costal-vertebral groove, with
egular contours (Fig. 5). This mass presented an interme-
iary signal on the T1-weighted sequences and a slightlyigure 5 Sagittal MRI reveals a well-circumscribed mass of
he posterior mediastinic space (case 5).
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one scintigraphy showed heterogenous hyperﬁxation at the
osterior arc of the left sixth rib. A left posterolateral thora-
otomy was performed. It demonstrated a tumor formation
entered on the posterior arc of the sixth rib. The tumor was
esected with dislocation of the head of the sixth rib and
esection of the posterior arc of the ﬁfth rib and the sixth
ntercostal space. On macroscopic examination, the sixth rib
as totally occupied by a bilobed tumor measuring 8 cm at
he widest point, with a multilobular and translucent aspect.
n histological examination, this aspect argued in favor of
rade II CS. The resection limits were not inﬁltrated.
After the intervention, ﬁve courses of chemotherapy and
7 sessions of radiotherapy were given. An X-ray of the
ib cage taken 1 year later showed radiation-induced costal
esions, with no evolving tumoral lesion. A thoracic CT scan
aken after 4 years showed no signs of recurrence or metas-
asis.
iscussion
rimary tumors of the ribs are rare and malignant in 29% of
ases. They are dominated by CS, which accounts for 40%
f all malignant tumors of the ribs [1]. The ﬁrst ﬁve ribs
re the most often affected and the lateral costal location
eems to be more frequent than anterior and posterior loca-
ions [3]. Rare before the age of 20 years, CS affects most
articularly middle-aged men, between the fourth and ﬁfth
ecades [4]. This male predominance was not found in our
eries, which included four women and one man. The time
apsed between the discovery of the lesions and consulta-
ion is usually long. In observations 1, 2, and 4, the delay
as, respectively, 9months, 5 years, and a few months. This
low progression is not a criterion indicating benign lesions
ecause these tumors usually progress in this way [5].
CS is the most often symptomatic and the major symptom
s pain, as was the case in four of our ﬁve patients. Swelling is
lso a frequent occurrence when the condition is discovered,
bserved in two of our patients. The pain involved and the
dherence to deep structures suggests malignity. A patho-
ogical rib fracture, hemothorax, or metastasis can bring
ut the diagnosis. In more than 90% of cases, CS appears
pontaneously de novo, with no preexisting lesion. In rare
ases, these lesions develop on a preexisting benign lesion,
uch as a chondroma or an osteochondroma, or in Paget dis-
ase. External thoracic irradiation and injuries can play an
tiopathogenic role in the origins of CS [6].
Biological exams contribute little useful information.
maging plays an important role in the diagnosis and man-
gement of chest wall tumors. The chest X-ray can orient
he diagnosis of costal CS by showing a seemingly pari-
tal opacity, a costal bone bulge, lumpy calciﬁcations that
re irregularly shaped and distributed, and a rib fracture
7]. Thoracic CT and MRI provide a better deﬁnition of
he tumor’s seat and extension. CT demonstrates a well-
imited, hypodense, rounded or multilobed parietal mass,
ith clumps of calciﬁcations, which are sometimes nodu-ar, predominating at the tumor’s periphery. Arc-shaped or
ing-shaped calciﬁcations can also be found, as illustrated
y observation 4. These calciﬁcations are not constant.
ostal or vertebral fractures as well as inﬁltration of the
urrounding soft tissues can be observed. The thoracic CT
m
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p
oD. Bacha et al.
can is generally sufﬁcient to decide on surgical resection.
RI, less speciﬁc than CT, shows a parietal mass, often
ith clear contours presenting an intermediary signal on
1-weighted sequences and a hyperintense signal on T2-
eighted sequences. The tumor looks heterogenous because
f the signal loss in areas of calciﬁcation. MRI provides
better conﬁguration of the cortical destruction and the
eriosteal reaction [3].
In our series, the radiological and clinical aspect sug-
ested a benign costal tumor in one case and a posterior
ediastinal neurologic tumor in another case. The deﬁnitive
iagnosis can only be established by anatomopathological
xaminations. Immediate wide resection of the tumor is
he best course whenever possible, allowing analysis of the
ntire lesion and minimizing the risk of recurrence and dis-
emination [5]. Fine-needle biopsy of the tumor often gives
nly poorly abundant material that is not highly represen-
ative of the tumor [8]. It should only be done in the case
here resection is not immediately feasible or at the price
f substantial sequelae, as illustrated by observation 1. In
hese cases, it can eliminate tumors whose treatment is not
xclusively surgical, such as Ewing sarcoma [5].
Macroscopically, the tumor is grayish in color, opaque,
oft in consistency, with a gelatinous aspect, sometimes
seudocystic. The cartilaginous islets are often voluminous,
oalescent, and poorly limited, with at most the loss of
he lobulated aspect of cartilaginous tumors. Histologically,
S is a malignant tumor with cartilaginous differentiation
ith no bone or osteoid production, but tumor-induced
r endochondral ossiﬁcation is observed. According to the
orld Health Organization (WHO) classiﬁcation, CS are
ivided into three grades of increasing aggressivity based
n cellular density, the degree of anisokaryosis, and nuclear
yperchromatism [9]:
grade I represents moderate cellular density. The nuclei
are hyperchromatic and uniform. Occasionally, a few bin-
ucleation aspects are noted. The cytological aspect is
close to that of benign chondroma;
grade II is characterized by higher cellular density.
The nuclei are more atypical and hyperchromatic. The
binucleate or multinucleate cells are observed more fre-
quently. Mitoses are rare (Fig. 6);
grade III is densely cellular. The tumor cells are pleomor-
phic and highly atypical. Mitoses are frequent (Fig. 7).
CS progresses spontaneously toward locoregional spread
nd the appearance of primarily pulmonary metastases, as
llustrated by observation 1 and the death.
Surgery is the only curative treatment [8], with the qual-
ty of the surgery an essential prognostic factor. Resection
hould be wide, taking the involved rib en bloc as well as the
wo intercostal spaces above and below, with a safety mar-
in of at least 4 cm, which can be less when there is contact
ith the vital organs but should also be greater than 2 cm.
he ﬁne-needle biopsy puncture trajectory should also be
xcised. If the neighboring organs such as the lung and the
uscles are invaded or adherent to the tumor, they must
e resected [5]. Wide excisions raise the problem of wall
econstruction, which should never make the surgical act
alliative and should restore the morphology and physiol-
gy of the thoracic wall. Many thoracic wall reconstruction
Costal chondrosarcoma. Report of ﬁve cases
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RFigure 6 Grade II CS: mesenchymal tumor with high cellular-
ity in a ﬁbrous and myxoid matrix. The cells show variation in
size and shape (HE× 100) (case 1).
methods exist, using autogenous biological material or a
synthetic material such as polypropylene and polytetraﬂu-
orethylene [6,10]. Radiotherapy and chemotherapy have a
limited effect. They are undertaken in cases of a volumi-
nous tumor that cannot be resected at once in an attempt to
reduce tumor size, as illustrated by observation 1. Adjuvant
treatments after surgery have not proven to be effective
[4]. In observation 5, the place of these adjuvant treat-
ments could not be clearly evaluated because the absence
of recurrence and metastasis 4 years after surgery could be
explained by the complete excision of the tumor. Treatment
of recurrences is also surgical [8].
The prognosis for CS is determined by its degree of his-
tological differentiation and by the quality of the surgical
excision. Other prognostic factors have been suggested,
such as tumor size and the onset of metastasis [5]. According
to some authors, cases of CS of the trunk have poorer prog-
nosis than CS affecting the limbs [11]. This may be explained
by the larger tumor size of CS located in the trunk at the time
of diagnosis, because their growth often goes unnoticed in
Figure 7 Grade III CS: marked pleomorphic cells, nuclear
atypia, and mitotic ﬁgures (HE× 250) (case 3).
[
[
[169
he chest wall or in the pelvic cavity, and because it can
e difﬁcult to remove the tumor completely with healthy
argins in cases of deep CS. Other authors consider that
he survival and local recurrence rates of CS located in the
hest wall are comparable to the rates of CS located else-
here, provided that the surgical margins are healthy [12].
ecurrences and metastases are frequent. Generally, recur-
ences occur within 3 years of surgical resection but can
ccur after a longer period in 37% of cases. Postoperative
linical follow-up is imperative every 3months for the ﬁrst
years and every 6months for at least 10 years, the duration
fter which a malignant tumor of the chest wall is considered
ured [10,7].
onclusion
ostal CS are rare tumors, characterized by a high poten-
ial of locoregional invasion, recurrence after treatment,
nd metastatic dissemination. Treatment is based essen-
ially on surgery, which can only be curative in tumors with
imited extension that are diagnosed early. This warrants
urveillance of benign bone lesions as well as rigorous and
rolonged follow-up of treated CS so that recurrence or
etastasis can be detected early.
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